Press Releases

09 Jan 2026

PExA’s lung cancer research instrument featured by Aftonbladet, Sweden’s largest news site

Aftonbladet, Sweden’s largest news site, is the latest in a series of major Swedish media outlets to highlight the research conducted by Professor Sandra Lindstedt and her research group at Lund University, where PExA’s patented research instrument is being used. On January 4, the newspaper published an in-depth article describing how Professor Lindstedt and her research group use…

Read more
18 Dec 2025

Wallenberg Fellow Utilizes PExA’s Research Instrument in Groundbreaking Vaccine and Antibody Study for Respiratory Infections

Professor Charlotte Thålin at Karolinska Institutet has been named a Wallenberg Academy Fellow 2025, receiving support for her research into airway antibodies. Her work is significantly enhanced by PExA’s patented research instrument, with the goal of developing a nasal spray capable of preventing respiratory infections. “Thanks to this instrument, we can now study antibodies in…

Read more
20 Nov 2025

PExA’s Research Instrument for Lung Cancer Detection Highlighted by Sweden’s Largest Radio News Programme

The research conducted by Professor Sandra Lindstedt and her team at Lund University, using PExA’s patented research instrument, received significant attention on Sunday in Sveriges Radio’s “Kvart i fem–Ekot” (the Quarter-to-Five News). The programme reported that the Lund researchers have identified a new and simple way to detect lung cancer, which could improve opportunities for earlier detection and thereby…

Read more
14 Nov 2025

SEK 27 million from the Swedish Cancer Society awarded to Sandra Lindstedt’s team in Lund for early detection of lung cancer

PExA congratulates Professor Sandra Lindstedt and her research group at Lund University on receiving SEK 27 million in research funding from the Swedish Cancer Society, as part of the organisation’s largest-ever initiative focused on the early detection of cancer. The project aims to develop a simple and non-invasive test for the early diagnosis of lung cancer by analysing exhaled particles. The method is…

Read more
31 Oct 2025

PExA awarded SEK 1 million from Vinnova for the next step toward lung-cancer diagnostics

PExA has been awarded SEK 1,000,000 in funding from Vinnova – Sweden’s Innovation Agency – for a project that supports the company’s strategic repositioning toward future diagnostic applications. The funding is granted within the call “Deepened collaborations with the USA, the United Kingdom and Singapore in health and life science.” The project, RAISE-lung, is carried out in…

Read more

Archive

Categories